These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 973876

  • 1. Effect of potassium-sparing diuretics on the renin-angiotensin-aldosterone system and potassium retention in heart failure.
    Nicholls MG, Espiner EA, Hughes H, Rogers T.
    Br Heart J; 1976 Oct; 38(10):1025-30. PubMed ID: 973876
    [Abstract] [Full Text] [Related]

  • 2. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ, Davies DL, Ferriss JB, Fraser R, Haywood E, Lever AF, Robertson JI.
    Br Med J; 1972 Jun 24; 2(5816):729-34. PubMed ID: 4338668
    [Abstract] [Full Text] [Related]

  • 3. Plasma renin in congestive heart failure in man.
    Vandongen R, Gordon RD.
    Med J Aust; 1970 Jan 31; 1(5):215-7. PubMed ID: 4314266
    [No Abstract] [Full Text] [Related]

  • 4. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
    Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P.
    Br Heart J; 1987 Jan 31; 57(1):17-22. PubMed ID: 3541995
    [Abstract] [Full Text] [Related]

  • 5. Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
    Svendsen UG, Ibsen H, Rasmussen S, Leth A, Nielsen MD, Dige-Petersen H, Giese J.
    Eur J Clin Pharmacol; 1986 Jan 31; 30(2):151-6. PubMed ID: 3519243
    [Abstract] [Full Text] [Related]

  • 6. Amiloride. A potassium-sparing natriuretic agent.
    Bull MB, Laragh JH.
    Circulation; 1968 Jan 31; 37(1):45-53. PubMed ID: 5634728
    [No Abstract] [Full Text] [Related]

  • 7. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure.
    Ikram H, Chan W, Espiner EA, Nicholls MG.
    Clin Sci (Lond); 1980 Dec 31; 59(6):443-9. PubMed ID: 7002435
    [Abstract] [Full Text] [Related]

  • 8. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 9. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE, Hettiarachchi J, Fraser R, Morton JJ.
    Clin Pharmacol Ther; 1980 Apr 17; 27(4):533-43. PubMed ID: 7357812
    [Abstract] [Full Text] [Related]

  • 10. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK, Larsen T, Vase H, Lauridsen TG, Jensen JM, Pedersen EB.
    Clin Exp Hypertens; 2013 Apr 17; 35(5):313-24. PubMed ID: 22966789
    [Abstract] [Full Text] [Related]

  • 11. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D, Beevers DG, Brown JJ, Davies DL, Ferriss JB, Fraser R, Lever AF, Robertson JI.
    Clin Sci Mol Med Suppl; 1973 Aug 17; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract] [Full Text] [Related]

  • 12. Metabolic effects of high dose amiloride and spironolactone: a comparative study in normal subjects.
    Millar JA, Fraser R, Mason P, Leckie B, Cumming AM, Robertson JI.
    Br J Clin Pharmacol; 1984 Sep 17; 18(3):369-75. PubMed ID: 6386025
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The use of digoxin, lasix and finoptin in treating circulatory failure in hypertension].
    Orynchak MA.
    Ter Arkh; 1989 Sep 17; 61(8):17-21. PubMed ID: 2686070
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
    Nicholls MG, Espiner EA, Ikram H, Maslowski AH, Lun S, Scandrett MS.
    J Clin Endocrinol Metab; 1981 Jun 17; 52(6):1253-6. PubMed ID: 7014601
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The renin-angiotensin-aldosterone system in compensated and uncompensated cardiac insufficiency].
    Sánchez Torres G, Posadas Romero C, Olvera S, Boyer Martínez JL, Guzmán Lara J, Serrano Mass P.
    Arch Inst Cardiol Mex; 1981 Jun 17; 51(2):147-52. PubMed ID: 7018436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.